Welcome to our news and online resources library


Perigord promote a culture of quality, operational excellence and GMP compliant processes. These documents share some of our experience in managing artwork through the artwork lifecycle process, and what we believe is critical in ensuring excellence. We hope you will find these resources helpful.

Articles


By Adriana Medina September 30, 2024
Selecting a Strategic Outsourcing Artwork and Labelling Partner in the DACH Region White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper
September 1, 2024
Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper
July 1, 2024
Advanced Artwork and Labelling Production Analytics White Paper Pharmaceutical Artwork Departments can accelerate business impact with Advanced Artwork and Labelling Production Analytics (AALPA)
By Adriana Medina November 6, 2023
Whitepaper zur Auswahl eines strategischen Partners für die Auslagerung von Artwork und Labelling in der D‑A‑CH-Region Wertsteigerung und Risikominderung durch Auslagerung an ein Fachunternehmen – ein Whitepaper zu bewährten Verfahren
October 6, 2020
Due to COVID-19, auditing as we know it is changing. In-person audits are increasingly being replaced by remote audits. Read our guide to a successful remote audit.
By Gary Orr July 16, 2019
Your company celebration and kudos does not last long as someone spots an artwork issue. In other words: here comes the recall. Yes, the worst-case scenario. We guess you won't sleep very well until this nightmare is over. If you are looking for fully compliant and error-free pharma artworks to hit the market efficiently while reducing your stress levels, keep an eye on the following four most common pharma artwork hurdles: One: Artwork process problems: Outdated and inefficient manual systems, systematic errors, inconsistencies, process gaps... all of them will develop into artwork errors. Too many assets, too many emails, too many people. Two: Compliance burdens: Labelling needs to be compliant with local regulations and current Good Manufacturing Practice, and this is probably the biggest concern for pharma companies. As these two become more and more complex over time, we need to ensure not only our company is fully aligned but also all the suppliers we use to go to market. Three: Speed issues: After the artwork change is agreed, there is a rush to go to market as soon as possible. Every day that passes without the product on the shelfs results in losses for the company. But working under huge pressure is when mistakes are more likely to happen. Four: Quality issues: Sometimes errors do not necessitate a recall, but they are still quality defects. Even though you don't have to start a recall, there can be potential quality control issues throughout the artwork process, and each of them have to be taken seriously. So, how to avoid these common pharma artwork hurdles? Pharma companies need to keep full control of their end-to-end artwork processes, making sure they are building quality into them. Reducing the risk of errors at every stage, ensuring they are 100% GMP compliant, and managing interactions and communications with stakeholders and suppliers are the key priorities. How to achieve that depends on the company, but one of the best ways today is through an Artwork Management System (AMS). Many of these are specifically designed for pharma companies to drive quality, security and GMP compliance while bringing better visibility to the full end-to-end artwork process. Top pharma companies are choosing GLAMS, (Global Artwork Management System), Perigord's pharma focused AMS, enables you to gain full control over your artwork processes, avoid hurdles, align with the industry regulations and thus improve your business results.
Show More

Webinars


By Adriana Medina July 9, 2024
Join industry leaders to hear first-hand how game-changing digital transformation is driving efficiency and removing risk across the content supply chain. Key Learning Objectives Include: Discover why Life Science companies are investing in digital impact analysis. Recognise the challenges faced by Life Science companies when determining the impact of a regulatory content change. See how a digital impact analysis tool can help you Asses and Visualise a regulatory change on the associated packaging and marketing content. Learn how digital impact analysis automates the cross-referencing of your regulatory changes with your artwork components. Gain insight into how digital impact analysis significantly enhances the efficiency of managing regulatory content changes through real-world use cases. Develop a comprehensive understanding of the automation techniques used for impact analysis, encompassing both exact and semantic phrases.
By Adriana Medina July 9, 2024
Access now to hear from our expert panel how having a connected packaging strategy can create an owned channel that links you directly with the HCP and Patient. Key Discussion Topics: Enriching HCP Engagement through connected packaging Improving Patient Safety and Medicine Adherence through connected experiences Building stronger Brand Awareness and Patient Engagement via digital content Providing greater Patient Support and access to the latest medical information
May 20, 2021
Join us and your industry peers for our latest Webinar "How the power of a connected AMS and automated proofreading solution will improve the efficiencies of your process and increase your speed to market" on-demand now where experts from Dr. Pfleger Arzneimittel GmbH, Perigord and Schlafender Hase will share their experience and demonstrate how having an AMS system with integrated digital comparison functionality will increase your speed to market, reduce the risk of product recall, and provide a full end-to-end audit trail of all approvals.
December 17, 2020
Perigord Life Science Solutions is delighted to announce we are joining Orphan Drug Consulting to bring you this latest Webinar, "Launching an RX Product in the EU – Fail to Prepare, Prepare to Fail," with our panel of speakers covering the different packaging and artwork requirements to launch a product in Europe, along with the key regulatory differences between the US and EU regulatory bodies, the launch process and more.
October 1, 2020
Join our subject matter experts on our latest webinar who will map out the packaging artwork and labelling journey from late stage 2 clinical trials to commercialisation and beyond. This webinar will chart a course through the complexities you will face as you prepare your product for the market. Reserve your seat:
Show More

Perigord Knowledge Centre


Perigord's Knowledge Centre

This new Knowledge Centre allows you to access information on all aspects of Life Science artwork production, management, process and more that has been gathered and curated by our team of experts and partners.


The library includes the following webinars and white papers:


  • Optimise the Artwork and Packaging Supply Chain in a World a Digital Transformation Webinar
  • Mind the Gap – Bridging the Packaging Divide Between R&D and Commercial Supply Webinar
  • Launching an Rx Product in the US – Fail to Prepare, Prepare to Fail Webinar
  • Launching an Rx Product in the EU – Fail to Prepare, Prepare to Fail Webinar
  • Another Driver Towards Digital Change, COVID-19 – Don't Get Left Behind Webinar
  • How the Power of a Connected AMS and Automated Proofreading Solution will Improve the Efficiencies of your Process Webinar
  • Digital Evolution in Impact Analysis for Regulatory Labelling and Artwork Changes Webinar
  • Best Practice for Remote Auditing in a GMP Environment White Paper
  • Selecting a Strategic Artwork and Labelling Partner White Paper


and more...

Join Now

Articles



By Adriana Medina September 30, 2024
Selecting a Strategic Outsourcing Artwork and Labelling Partner in the DACH Region White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper
September 1, 2024
Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper
July 1, 2024
Advanced Artwork and Labelling Production Analytics White Paper Pharmaceutical Artwork Departments can accelerate business impact with Advanced Artwork and Labelling Production Analytics (AALPA)
Show More

Press Releases, News & Updates


May 5, 2021
Dublin, Ireland – May 05, 2021: Deep search capabilities and extensive integration options amongst suite of enhancements for life science-specific artwork management system GLAMS 5 Perigord announces the release of GLAMS 5.0 , the latest update to its industry-leading AMS platform. Developed to the specific needs of the Life Science industry, this latest release boasts an expanded suite of both new and improved features, as well as greatly improved performance. Perigord Data’s Chief Operations Officer, Suzanne Ivory explained, “GLAMS 5’s new deep search capabilities break down potential impediments to getting products to market, and allows users to create deep and wide-ranging searches of all their artwork data, including querying active text on any uploaded PDFs, making it possible to gather a huge amount of rich, context-filled information quickly, easily, and efficiently . ” With its history of innovation and close cooperation with some of the world’s biggest pharmaceutical companies, Perigord’s development team has added several new features to GLAMS to greatly increase the usability and productivity of the platform for its users. These include: Advanced search capabilities Enhanced built-in proofing and reporting tools Configurable document stamping Extensive integration enhancements Multilingual versions Performance improvements “ Listening to our customers and leveraging our own experience, we have spent several months refining the GLAMS platform , ” explained Paul Leamy, Group CTO and Head of Product Innovation at Perigord Data . “ We have added new functionality and increased the processing speed across our product suite. Not only do the new features offer our clients a more holistic experience when managing their artwork, GLAMS 5.0 will greatly improve the speed, usability, scalability, and efficiency of the artwork and labelling process across all phases of the packaging and labelling supply chain for our clients .” GLAMS is the only artwork management system built specifically for the exacting requirements of the Life Science industry and the release of GLAMS 5 is a further step toward cementing Perigord’s reputation as the go-to AMS solution provider in the sector. “ It is Perigord’s extensive expertise and experience that enables us to develop solutions that streamline the approval process and other aspects of artwork and labelling workflows, essentially removing the bottlenecks that delay the packaging development process ,” commented Perigord Data’s Director of Client Services, Sam Cole . Introducing GLAMS 5’s new features: Advanced search capabilities – Leveraging the power of OCR technology, the scope of GLAMS 5’s capabilities have increased massively, allowing users to search the text of supporting or approval documents. Searches have also been made faster and more intuitive, enhancing clients’ capacity to access artwork tasks quicker, create complex, ad hoc queries conveniently, and deliver even greater efficiency to the process. Enhancements to integrated proofing and reporting tools – Clients can seamlessly integrate with the newest versions of InformaIT, GlobalVision, TVT and other leading comparison tools on the market as well as enjoying improvements to the GLAMS 3D visualisation functionality. These enhancements also provide customers with the added ability to autosave reports from third-party applications directly into GLAMS jobs. Configurable document stamping – This extension to the existing GLAMS stamping functionality allows multiple approver stamps to be shown in a table on a separate page inserted into an approved artwork PDF. This improvement also allows for the inclusion of pagination on stamping activities, making quality assurance processes more configurable, more efficient, and providing greater traceability in offline, printed artwork and graphic files. Approver stamps are clearer and more easily located and viewed. Extensive integration upgrades – Updates to the GLAMS API layer deliver improved connectivity to external systems and make GLAMS the most integration-ready AMS on the market. This will enable users to send and receive data from a variety of sources including ERP systems like SAP or Oracle, as well as Regulatory Information, Documents Management, Change Control, and PLM systems, unleashing a huge range of digital capabilities. Multilingual versions – The GLAMS user interface can now be tailored to clients’ language preferences. Pre-configured, multi-lingual options now include Japanese and Mandarin, with the facility to add additional language packs as required. Performance improvements – Perigord’s continued focus on under-the-hood investment has led to a raft of improvements that speed up the loading of data in grids and drop-down values, allowing for faster job scheduling, quicker search replies and more efficient data export. These performance improvements deliver quicker response times, enhancing the user experience. “ With the new functionality and system improvements included in GLAMS 5.0, I am confident that GLAMS is the best Life Science artwork management system on the market ,” said Perigord Data’s COO, Suzanne Ivory . “ The improvements incorporated into GLAMS 5.0 represent not only the cutting edge of AMS technology, but also its continuing evolution toward fulfilling our overall vision of providing a holistic, end-to-end content management solution that provides for all labelling requirements on a regulatory, marketing or packaging level. ” “ Working with our product development team, I look forward not only to expanding and improving on the existing performance of the system, but also to introducing new and innovative functionality that will allow our clients take advantage of the technological revolution taking place in content management ,” Mrs Ivory concluded. About GLAMS For Life Science organisations, managing artwork packaging and marcom workflows is complex, time consuming and prone to error. With labelling and artwork playing such a critical role in the regulatory mandated communication of medicinal formulation, usage instruction, safety and efficacy data and patient information, mistakes can happen! Involving thousands of people across multiple locations, keeping track of all artwork and labelling tasks, approvals and project timelines is a very challenging and costly exercise. Mistakes cause severe delays in product market launches, full product recalls and, in the worst cases, adverse patient reactions. To mitigate these risks, it is imperative that Life Science organisations have a fully validated and auditable artwork management system in place – a system that simplifies the packaging artwork labelling and regulatory processes and improves productivity. Designed and developed specifically for the Life Science industry Perigord’s GLAMS solution has one key differentiator from its AMS competitors – GLAMS is exclusively designed and developed for the Life Science industry. This means that every aspect of the solution, from the base architecture to each function, has a context that resonates with our Life Science partners. This makes the solution footprint more compact, simpler to understand, faster to validate and quicker to implement when compared with generic non-Life Science AMS solutions. Implementing GLAMS will have an immediate positive impact on your business, with measurable benefits far outweighing the cost of ownership. GLAMS is the only Artwork Management System dedicated to the sector and specifically designed to help reduce risk, speed up artwork turnaround times, remove duplication of effort, and deliver greater business value. Available from May 2021 onwards – for further insights and technical information, as well as learning new ways to boost business productivity, efficiency, and profitability: Request a demo at: www.glams.com/sign-up/request-demo/ For more information contact your GLAMS Account Manager or: Mark Ennis Global Business Development Director mark.ennis@perigord-as.com Steven Gaffney Business Development Executive steven.gaffney@perigord-as.com Perigord Life Science Solutions Unit 1, Lyncon Court IDA Business & Technology Park Snugborough Road, Blanchardstown Dublin, D15 N283, Ireland mediarelations@perigord-as.com Tel: +353 1 440 3222 www.GLAMS.com
March 15, 2021
Tech Mahindra Acquires Majority Stake in Perigord Life Science Solutions Tech Mahindra acquires 70% equity stake to augment domain expertise in the global Pharmaceutical, Healthcare and Life Science sectors
February 11, 2021
We are delighted to announce the launch of our new Independent Packaging & Labelling Inspection Service . Over the years, we have worked with a number of organisations providing artwork production and coordination services around the globe. Increasingly we have been requested to support more and more of the proofing and inspection tasks companies such as yours need to carry out, these include a range of critical checks across the product packaging life cycle, be they: Pre-Artwork Checks Production Artwork Checks Braille Confirmation Barcode Review Technical Artwork Revisions Text Content Verification Printer Proofing As a result of this demand, we have set up a specific independent team to carry out these inspections of organisations' artwork – no matter the source. To learn more about this new service, please click below:
Show More
Share by: